LB Cantor, J Hoop, L Morgan, D WuDunn, Y … - British Medical Journal, 2006 - bjo.bmj.com Results: No significant between-group differences were observed in IOP at
baseline, at 09:00, 13:00 or 16:00 h (p 0.741). After 6 months, both drugs
significantly reduced IOP at every time point (p 0.001). After 6 months, ... Cited by 10 - Related articles - BL Direct - All 11 versions
RJ Noecker, ML Earl, TK Mundorf, SM … - Current Medical Research and Opinion®, 2006 - informahealthcare.com Objective: To compare the intraocular pressure- lowering efficacy and safety of
topical bimatoprost 0.03% with that of travoprost 0.004% for the treatment of
black patients with open-angle glaucoma (OAG) and ocular hypertension ... Cited by 5 - Related articles - BL Direct - All 5 versions
ME Arranz, GMA Teus, GF Canseco - Archivos de la Sociedad Española de Oftalmología, 2002 - ncbi.nlm.nih.gov PURPOSE: To study the respiratory effects of chronic therapy with latanoprost in
Chronic Obstructive Pulmonary Disease (COPD) patients. METHODS: We prospectively
performed a spirometry in 19 COPD patients treated with latanoprost for ... Cited by 2 - Related articles - BL Direct
IF Hepsen, E Ozkaya - Eye, 2006 - nature.com Eye is the official journal of the Royal College of Ophthalmologists. It aims to
provide the practising ophthalmologist with information on the latest clinical ... Cited by 10 - Related articles - BL Direct - All 4 versions
RJ Noecker, ML Earl, T Mundorf, J Peace, RD … - Advances in therapy, 2003 - Springer This randomized, investigator-masked, multicenter, parallel-design trial
compared the IOP-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in
African Americans with glaucoma or ocular hypertension. After a washout of ... Cited by 23 - Related articles - BL Direct - All 3 versions
LB Cantor, D WuDunn, A Cortes, J Hoop, S … - Survey of ophthalmology, 2004 - Elsevier At the baseline visit, there were no significant between-group differences in
IOP at 9 , 1 , or 4 (P≥.776). After 6 months of therapy, both medications
provided significant mean reductions from baseline IOP at every time point ... Cited by 25 - Related articles - All 5 versions
E Arranz-Marquez, MA Teus, MA Saornil, MC … - American journal of ophthalmology, 2004 - Elsevier Iris biopsies of eyes treated with latanoprost were analyzed (all had a
photographically documented increase in iris pigmentation) plus control eyes
(untreated with prostanoids) using optical microscopy. patient or study ... Cited by 12 - Related articles - All 12 versions
N Li, X Chen, Y Zhou, M Wei, X Yao - Clinical and Experimental Ophthalmology, 2006 - interscience.wiley.com Background: It is still uncertain whether travoprost has comparable or better
efficacy compared with other prostaglandin analogues or timolol in patients with
open-angle glaucoma or ocular hypertension. The authors performed a meta- ... Cited by 22 - Related articles - BL Direct - All 3 versions
N Pfeiffer, I Grierson, H Goldsmith, P … - Archives of Ophthalmology, 2003 - archopht.highwire.org Methods Seventeen patients with bilateral primary open-angle glaucoma requiring
trabeculectomy were recruited for this study. The iridectomy taken during
surgery on the first eye served as a control. The second test eye was ... Cited by 14 - Related articles - BL Direct - All 4 versions
